Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis

(2015) C Blick et al.   BRITISH JOURNAL OF CANCER

Prognostic Impact of Hypoxia-InduciblemiRNA-210in Patients with Lung Adenocarcinoma

(2015) Jun Osugi et al.   Journal of Oncology

Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response

(2014) X. Huang et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer

(2014) B A Hunter et al.   BRITISH JOURNAL OF CANCER

Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis

(2014) Jian Wang et al.   PLoS One

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis

(2013) R I McCormick et al.   BRITISH JOURNAL OF CANCER

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

(2013) A. Eustace et al.   CLINICAL CANCER RESEARCH

Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1

(2013) Woochul Chang et al.   Journal of Veterinary Science

Positive prognostic impact of miR-210 in non-small cell lung cancer

(2013) Marte Eilertsen et al.   LUNG CANCER

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial

(2013) Amanda Eustace et al.   RADIOTHERAPY AND ONCOLOGY

Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation

(2012) J S Hall et al.   BRITISH JOURNAL OF CANCER

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

(2012) Nicholas D. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells

(2011) Imran A. Babar et al.   CANCER BIOLOGY & THERAPY

Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer

(2011) Ananya Choudhury et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1  Activity during Prolonged Hypoxia

(2011) U. Bruning et al.   MOLECULAR AND CELLULAR BIOLOGY

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene

(2010) F M Buffa et al.   BRITISH JOURNAL OF CANCER

Hypoxic regulation of miR-210: Shrinking targets expand HIF-1’s Influence

(2010) Paul G. Corn   CANCER BIOLOGY & THERAPY

MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT

(2010) Zhan Zhang et al.   CELL CYCLE

Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma

(2010) Peter J. Hoskin et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation

(2009) Xin Huang et al.   MOLECULAR CELL

hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer

(2008) C. Camps et al.   CLINICAL CANCER RESEARCH